DC

Defu Capital

Description

Defu Capital is an investment firm.

Investor Profile

Defu Capital has made 2 investments, with 0 in the past 12 months and 100% as lead.

Stage Focus

  • Series Unknown (50%)
  • Series C (50%)

Country Focus

  • China (100%)

Industry Focus

  • Biotechnology
  • Genetics
  • Manufacturing
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Defu Capital frequently co-invest with?

Greenwoods Investment
Asia, Shanghai, China, Shanghai
Co-Investments: 1
CASH Capital
Asia, Beijing, China, Beijing
Co-Investments: 1
DeFi Capital
Europe, Utrecht, The Netherlands, Utrecht
Co-Investments: 1
Huagai Capital
Asia, Beijing, China, Beijing
Co-Investments: 1
GF Qianhe Investment
Asia, Beijing, China, Beijing
Co-Investments: 1
Novo Holdings
Europe, Hovedstaden, Denmark, Hellerup
Co-Investments: 1
GL Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 1
CPE
Asia, Beijing, China, Beijing
Co-Investments: 1

What are some of recent deals done by Defu Capital?

Sangon Biotech

Shanghai, Shanghai, China

Sangon Biotech is engaged in the research and development of chemical synthesis of DNA.

BiotechnologyGenetics
Series UnknownApr 19, 2023
Amount Raised: $290,440,162
Bohai New Enzyme

Shanghai, Shanghai, China

Bohai New Enzyme is a special enzyme research and development manufacturer.

Manufacturing
Series CNov 5, 2021
Amount Raised: $125,021,488